Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 2199
  • 2200
  • 2201
  • …
  • ›
  • »

2025/11/18 22:39

NX Investors Have Opportunity to Lead Quanex Building Products Corporation Securities Fraud Lawsuit with the Schall Law Firm

2025/11/18 22:39

KBRA Assigns Preliminary Ratings to Angel Oak Mortgage Trust 2025-12 (AOMT 2025-12)

2025/11/18 22:36

M&T Bank Corporation Announces Fourth Quarter Common Stock Dividend

2025/11/18 22:36

Forget Westpac, these strong ASX dividend shares could be top buys

2025/11/18 22:36

M&T Bank declares $1.50 dividend

2025/11/18 22:36

Golub Capital Q4 earnings, slightly exceeding consensus, stalls sequentially

2025/11/18 22:36

Nexstar files with FCC to get clearance for its $3.54B TEGNA takeover

2025/11/18 22:36

Power Integrations names Nancy Erba as CFO

2025/11/18 22:36

B. Riley Financial GAAP EPS of -$0.39, revenue of $186.06M

2025/11/18 22:33

Celebrate the Season Sustainably and Make Energy Efficiency a Holiday Tradition

2025/11/18 22:33

AAR publishes 2025 Sustainability Report

2025/11/18 22:33

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025

  • «
  • ‹
  • …
  • 2199
  • 2200
  • 2201
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies